IVF_INSPIRE IVF
Inspire IVF Public Company Limited operates an infertility treatment center in Thailand. The company offers intrauterine insemination, preimplantation genetic testing, intracytoplasmic sperm injection, embryo transfer, fertility preservation, preventive and regenerative medicine, health checkup, and other infertility treatments. It provides obstetrics and gynecology examinations, consulting, and … Read more
IVF_INSPIRE IVF (IVF) - Total Liabilities
Latest total liabilities as of September 2024: ฿84.37 Million THB
Based on the latest financial reports, IVF_INSPIRE IVF (IVF) has total liabilities worth ฿84.37 Million THB as of September 2024.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
IVF_INSPIRE IVF - Total Liabilities Trend (2021–2023)
This chart illustrates how IVF_INSPIRE IVF's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
IVF_INSPIRE IVF Competitors by Total Liabilities
The table below lists competitors of IVF_INSPIRE IVF ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
INTUITIVE SURGICAL (IUI1.SG)
STU:IUI1
|
Germany | €2.07 Billion |
|
Constellation Resources Ltd
AU:CR1
|
Australia | AU$494.25K |
|
Ilyda SA
AT:ILYDA
|
Greece | €1.78 Million |
|
New England Realty Associates LP
NYSE MKT:NEN
|
USA | $563.89 Million |
|
NEP Realty and Industry Public Company Limited
BK:NEP
|
Thailand | ฿6.62 Million |
|
Pharma-Bio Serv Inc
OTCQB:PBSV
|
USA | $1.74 Million |
|
Kohinoor Foods Limited
NSE:KOHINOOR
|
India | ₹3.83 Billion |
|
Standard Industries Limited
NSE:SIL
|
India | ₹441.07 Million |
Liability Composition Analysis (2021–2023)
This chart breaks down IVF_INSPIRE IVF's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 6.32 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.49 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.33 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how IVF_INSPIRE IVF's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for IVF_INSPIRE IVF (2021–2023)
The table below shows the annual total liabilities of IVF_INSPIRE IVF from 2021 to 2023.
| Year | Total Liabilities | Change |
|---|---|---|
| 2023-12-31 | ฿83.01 Million | -12.91% |
| 2022-12-31 | ฿95.31 Million | +0.36% |
| 2021-12-31 | ฿94.97 Million | -- |